SG11201407314XA - Compositions and methods for the treatment of diabetes - Google Patents
Compositions and methods for the treatment of diabetesInfo
- Publication number
- SG11201407314XA SG11201407314XA SG11201407314XA SG11201407314XA SG11201407314XA SG 11201407314X A SG11201407314X A SG 11201407314XA SG 11201407314X A SG11201407314X A SG 11201407314XA SG 11201407314X A SG11201407314X A SG 11201407314XA SG 11201407314X A SG11201407314X A SG 11201407314XA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- diabetes
- compositions
- treatment
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 14 November 2013 (14.11.2013) WIPOIPCT (10) International Publication Number WO 2013/167987 A1 (51) International Patent Classification: C07C 233/63 (2006.01) A61K31/10 (2006.01) A61K31/198 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/IB2013/050744 29 January 2013 (29.01.2013) English English (30) Priority Data: 1788/CHE/2012 8 May 2012 (08.05.2012) IN (72) Inventor; and (71) Applicant : KANDULA, Mahesh [IN/IN]; Door No. 11- 61, Samalkot Mandal, East Godavari Dist, G.Medapadu 533 434, Andhra Pradesh (IN). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) l> 00 o\ l> i-H en i-H o CJ o & (54) Title: COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES (57) Abstract: The invention relates to the compounds of formula (I) or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of com pounds of formula (I), and methods for treating or preventing diabetes may be formulated for oral, buccal, rectal, topical, trans - dermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of metabolic syndrome, insulin resistance, glucose intolerance, hyperinsulinemia, diabetes mellitus, diabetes insipidus, hyperglycemia and diabetic complications.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1788CH2012 | 2012-05-08 | ||
PCT/IB2013/050744 WO2013167987A1 (en) | 2012-05-08 | 2013-01-29 | Compositions and methods for the treatment of diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201407314XA true SG11201407314XA (en) | 2014-12-30 |
Family
ID=54193689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201407314XA SG11201407314XA (en) | 2012-05-08 | 2013-01-29 | Compositions and methods for the treatment of diabetes |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2847161A4 (en) |
JP (1) | JP2015521174A (en) |
CN (1) | CN104364230A (en) |
AU (1) | AU2013257708A1 (en) |
CA (1) | CA2873084A1 (en) |
SG (1) | SG11201407314XA (en) |
WO (1) | WO2013167987A1 (en) |
ZA (1) | ZA201408065B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013257745A1 (en) * | 2012-05-07 | 2014-11-27 | Cellixbio Private Limited | Prodrugs of anti-platelet agents |
AU2013285126A1 (en) * | 2012-07-03 | 2014-11-27 | Cellixbio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
JPWO2022065133A1 (en) * | 2020-09-25 | 2022-03-31 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2288997T3 (en) * | 2000-10-24 | 2008-02-01 | Ajinomoto Co., Inc. | PROCEDURE FOR PRODUCING CRYSTALS OF NATEGLINIDA TYPE B. |
JP4615866B2 (en) * | 2002-04-15 | 2011-01-19 | ノバルティス アーゲー | Crystal form of N- (trans-4-isopropylcyclohexylcarbonyl) -D-phenylalanine |
US9085527B2 (en) * | 2008-07-08 | 2015-07-21 | Catabasis Pharmaceuticals, Inc. | Fatty acid acylated salicylates and their uses |
US8946451B2 (en) * | 2009-10-05 | 2015-02-03 | Catabasis Pharmaceuticals, Inc. | Lipoic acid acylated salicylate derivatives and their uses |
-
2013
- 2013-01-29 EP EP13787016.8A patent/EP2847161A4/en not_active Withdrawn
- 2013-01-29 CN CN201380030645.3A patent/CN104364230A/en active Pending
- 2013-01-29 JP JP2015510894A patent/JP2015521174A/en active Pending
- 2013-01-29 CA CA2873084A patent/CA2873084A1/en not_active Abandoned
- 2013-01-29 WO PCT/IB2013/050744 patent/WO2013167987A1/en active Application Filing
- 2013-01-29 AU AU2013257708A patent/AU2013257708A1/en not_active Abandoned
- 2013-01-29 SG SG11201407314XA patent/SG11201407314XA/en unknown
-
2014
- 2014-11-04 ZA ZA2014/08065A patent/ZA201408065B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201408065B (en) | 2016-04-28 |
CA2873084A1 (en) | 2013-11-14 |
WO2013167987A1 (en) | 2013-11-14 |
EP2847161A1 (en) | 2015-03-18 |
AU2013257708A1 (en) | 2014-12-04 |
CN104364230A (en) | 2015-02-18 |
JP2015521174A (en) | 2015-07-27 |
EP2847161A4 (en) | 2015-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201407411SA (en) | Compositions and methods for the treatment of metabolic syndrome | |
SG11201407326XA (en) | Compositions and methods for treatment of mucositis | |
SG11201408094YA (en) | Neprilysin inhibitors | |
SG11201408095XA (en) | Fibroblast growth factor 21 proteins | |
SG11201407533SA (en) | Antiviral compounds | |
SG11201805838UA (en) | Macrocyclic mcl1 inhibitors for treating cancer | |
SG11201408539UA (en) | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof | |
SG11201407037UA (en) | Catechol o-methyltransferase activity inhibiting compounds | |
SG11201408261UA (en) | Syringe | |
SG11201407303SA (en) | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders | |
SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
SG11201407115XA (en) | Carboxylic acid compounds | |
SG11201407317SA (en) | Compositions and methods for suppression of carbonic anhydrase activity | |
SG11201407184PA (en) | Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals | |
SG11201408750VA (en) | NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS | |
SG11201407534PA (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
SG11201407596TA (en) | Conjugation reagents | |
SG11201408629QA (en) | Dimethyl-benzoic acid compounds | |
SG11201408332TA (en) | Polyisobutylene composition having internal vinylidene and process for preparing the polyisobutylene polymer composition | |
SG11201407319YA (en) | Compositions and methods for treatment of inflammatory bowel disease | |
SG11201909376TA (en) | Crystalline forms of a jak inhibitor compound | |
SG11201408685WA (en) | Antibacterial microelement chelates and the use thereof in animal feeds | |
SG11201407934UA (en) | Camsylate salt | |
SG11201408641UA (en) | Phenoxyethyl piperidine compounds | |
SG11201407323WA (en) | Compositions and methods for the treatment of local pain |